DAY Wesley | Drug Metabolism Department, Central Research Division, Pfizer Inc.
スポンサーリンク
概要
Drug Metabolism Department, Central Research Division, Pfizer Inc. | 論文
- Determination of trovafloxacin, a new quinolone antibiotic, in biological samples by reversed-phase high-performance liquid chromatography
- Quantitation of 4-cyclohexyl-2-hydroxy-3-(3-methylsulfanyl-2-{2-[(morpholine-4-carbonyl)amino]-3-phenylpropionylamino}propionylamino)butyric acid isopropyl ester (CP-80,794), a renin inhibitor, and its hydrolytic cleavage metabolite 2-[(morpholine-4-carbo